We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
–
AUM
$3.96B
AUM Growth
+$78.3M
Cap. Flow
+$64.4M
Cap. Flow %
1.63%
Top 10 Hldgs %
19.08%
Holding
1,323
New
91
Increased
697
Reduced
400
Closed
115

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$84.8M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$78.7M
3
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$48.8M
4
DVY icon
iShares Select Dividend ETF
DVY
+$42.3M
5
META icon
Meta Platforms (Facebook)
META
+$23.9M

Top Sells

Rank Stock Value
1
HYMB icon
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
+$67.2M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$56.5M
3
JEPI icon
JPMorgan Equity Premium Income ETF
JEPI
+$49.5M
4
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$48.9M
5
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 21.92%
2 Energy 13.11%
3 Healthcare 9.27%
4 Industrials 7.64%
5 Communication Services 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EME icon
876
Emcor
EME
$33B
$201K 0.01%
550
+525
+2,100% +$194K
ARIS
877
DELISTED
Aris Water Solutions
ARIS
$199K 0.01%
12,670
+7,765
+158% +$116K
SNDX icon
878
Syndax Pharmaceuticals
SNDX
$1.82B
$197K 0.01%
9,595
-2,985
-24% -$62.5K
TYRA icon
879
Tyra Biosciences
TYRA
$1.85B
$196K ﹤0.01%
12,245
-3,808
-24% -$65.5K
NUVL
880
DELISTED
Nuvalent
NUVL
$195K ﹤0.01%
2,570
-798
-24% -$56.8K
BCYC
881
Bicycle Therapeutics
BCYC
$276M
$192K ﹤0.01%
9,474
-2,947
-24% -$66.6K
ROL icon
882
Rollins
ROL
$18.8B
$190K ﹤0.01%
3,891
+922
+31% +$42.6K
BNTX icon
883
BioNTech
BNTX
$23B
$188K ﹤0.01%
2,340
-727
-24% -$66.5K
XNCR icon
884
Xencor
XNCR
$1.47B
$187K ﹤0.01%
9,866
-3,068
-24% -$65.9K
PRLD icon
885
Prelude Therapeutics
PRLD
$310M
$186K ﹤0.01%
48,727
-15,160
-24% -$61.7K
RCUS icon
886
Arcus Biosciences
RCUS
$3.5B
$181K ﹤0.01%
11,863
-3,690
-24% -$59.6K
GMAB icon
887
Genmab
GMAB
$17.7B
$180K ﹤0.01%
7,174
-2,230
-24% -$63.2K
DKS icon
888
Dick's Sporting Goods
DKS
$18.4B
$177K ﹤0.01%
+825
New +$172K
YMAB
889
DELISTED
Y-mAbs Therapeutics
YMAB
$175K ﹤0.01%
14,489
-4,507
-24% -$60.8K
RLAY icon
890
Relay Therapeutics
RLAY
$4.06B
$173K ﹤0.01%
26,600
-8,276
-24% -$56.5K
ACLX
891
DELISTED
Arcellx
ACLX
$172K ﹤0.01%
3,125
-971
-24% -$52.8K
ZYME icon
892
Zymeworks
ZYME
$1.69B
$172K ﹤0.01%
20,180
-6,276
-24% -$55.9K
IDYA icon
893
IDEAYA Biosciences
IDYA
$3.54B
$170K ﹤0.01%
4,851
-1,509
-24% -$59.8K
IPHA
894
Innate Pharma
IPHA
$166M
$167K ﹤0.01%
86,237
-26,833
-24% -$67.4K
EXAI
895
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$167K ﹤0.01%
32,680
-10,167
-24% -$50.1K
SWTX
896
DELISTED
SpringWorks Therapeutics
SWTX
$165K ﹤0.01%
4,392
-1,367
-24% -$57.5K
KYMR icon
897
Kymera Therapeutics
KYMR
$9.05B
$164K ﹤0.01%
5,502
-1,710
-24% -$59.2K
SDGR icon
898
Schrodinger
SDGR
$1.14B
$163K ﹤0.01%
8,440
-2,625
-24% -$60.5K
STRO icon
899
Sutro Biopharma
STRO
$398M
$159K ﹤0.01%
5,420
-1,686
-24% -$66.7K
TPL icon
900
Texas Pacific Land
TPL
$27.4B
$159K ﹤0.01%
648
+63
+11% +$13.2K
34 35
36
37 38

Similar funds

DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
AM
AGF Management Toronto, Ontario, Canada $22.3B AUM 46.42% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Exchange Traded Concepts's Q2 2024 Portfolio in Review

As of Q2 2024, Exchange Traded Concepts held 1,323 positions worth $3.96B, up 2% from $3.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Exchange Traded Concepts's Q2 2024 filing shows 91 new, 697 increased, 400 reduced and 115 closed positions. Its largest new stake was iShares Select Dividend ETF: 348,331 shares worth $42.1M. The largest sale was State Street SPDR Nuveen ICE High Yield Municipal Bond ETF, an estimated $67.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Energy and Healthcare.

  • Exchange Traded Concepts's largest Q2 2024 buy was iShares Select Dividend ETF: 348,331 shares worth $42.1M.
  • Exchange Traded Concepts added most to State Street Health Care Select Sector SPDR ETF in Q2 2024, an estimated $84.8M increase.
  • Exchange Traded Concepts's biggest Q2 2024 reduction was State Street SPDR Nuveen ICE High Yield Municipal Bond ETF, cutting an estimated $67.2M.
  • Exchange Traded Concepts fully exited Janus Henderson AAA CLO ETF in Q2 2024, selling an estimated $48.9M.
  • Exchange Traded Concepts's ten largest holdings make up 19% of its $3.96B portfolio in Q2 2024.
  • Exchange Traded Concepts opened 91 new positions and closed 115 in Q2 2024.
  • Exchange Traded Concepts's portfolio value rose 2% quarter-over-quarter to $3.96B.

Based on Exchange Traded Concepts's 13F filing for Q2 2024, filed 13 Aug 2024.